Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Onyx gets milestone payment from partner Pfizer. More...
Complex deal with Bayer increase sales...
Medarex could get as much as $610MM to develop 50...
Vioxx puts another nail in the Blockbuster Drug Coffin....
But Trouble Anglo-Swedish pharmaceutical company...
The Delicate Dance of Regulatory Approvals. More details...
Revenues are up 50%. More details...
Index up 12. More details...
Dr. David Graham and the Dysfunctional FDA. More details...
Drug Could Hit Market in Six Months. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
